Skip to main content

Table 1 Characteristics of the patients with de novo immune hepatitis and chronic rejection

From: Identification of the cellular components involved in de novo immune hepatitis: a quantitative immunohistochemical analysis

Patient

Gender

Original disease

Baseline IS

Biopsy date (biopsy #)

Months after LT

Diagnosis

1

F

Drug toxicity

CYA, AZA, ST

18-02-00a

21

dnIH

2

M

Alcoholic cirrhosis

CYA(N), MMF, ST

15-03-04a

58

dnIH

3

M

HCV + alcoholic cirrhosis

CYA(N), ST, anti-CD25

13-07-04 (B1)a

05-09-04 (B2)

32

34

dnIH

4

F

Alcoholic cirrhosis

CYA, MMF, ST

16-07-04 (B1)a

13-06-05 (B2)

10

21

dnIH

5

F

Unknown

CYA, MMF, ST

28-01-10a

32

dnIH

6

F

PBC

CYA, MMF, ST

19-04-10a

13

dnIH

7

F

HCV cirrhosis

CYA, MMF, ST

30-07-12 (B1)

05-12-12 (B2)a

3

8

HCV + AR

dnIH

8

M

HCV cirrhosis

TAC, ST

28-12-00a

14

dnIH

9

F

HCV cirrhosis

CYA, MMF, ST

18-06-09a

57

dnIH

10

F

SBC

CYA (N), MMF, ST

19-02-14a

87

dnIH

11

F

HCV cirrhosis

CYA, AZA, ST

25-04-97a

7

dnIH

12

F

HCV cirrhosis

CYA(N), ST, anti-CD25

04-02-02a

19

dnIH

CR-1

F

HCV cirrhosis

TAC, MMF, ST

09-11-04

29

CR

CR-2

F

PBC

Sotrastaurin

01-11-11

12

Early CR

CR-3

M

Caroli disease

TAC, MMF, ST

08-03-13

17

CR

CR-4

M

Alcoholic cirrhosis + NASH

TAC, MMF, ST, anti-CD25

30-07-13

6

Early CR

CR-5

M

HCV cirrhosis + HC

CYA, MMF, ST

07-06-13

11

CR

CR-6

M

Cryptogenic

TAC, MMF, ST

08-03-12

9

Early CR

CR-7

M

Re-transplant

TAC, MMF, ST

05-08-10

74

CR

CR-8

M

Alcoholic cirrhosis

TAC, anti-CD25

12-03-14

84

CR

CR-9

M

PBC

TAC, anti-CD25

22-01-07

75

CR

  1. M, male; F, female; LT, liver transplant; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; SBC, secondary biliary cirrhosis; IS, immunosuppression; TAC, tacrolimus; AR, acute rejection; CYA, cyclosporine; N, Neoral; MMF, mofetil mycophenolate; ST, steroids; AZA, azathioprine; dnIH, de novo immune hepatitis; CR, chronic rejection; NASH, non-alcoholic steatohepatitis; HC, hepatocellular carcinoma
  2. adnIH diagnostic biopsy